![](https://www.biospectrumasia.com/uploads/articles/gene-24465.jpg)
US FDA expands approval of gene therapy for patients with Duchenne Muscular Dystrophy
Granted the approval and accelerated approval for Elevidys to Sarepta Therapeutics Inc. The US Food and Drug Administration (FDA) has expanded the approval of Elevidys (delandistrogene moxeparvovec-rokl), a gene therapy for the treatment of Duchenne …